IgG N-glycans as potential biomarkers for determining galactose tolerance in Classical Galactosaemia.
AuthorsCoss, K P
Byrne, J C
Coman, D J
Abrahams, J L
Brown, A Y
Rudd, P M
Treacy, E P
AffiliationUniversity College Dublin, Clinical Research Centre, Mater Misericordiae University Hospital, Ireland.
MetadataShow full item record
CitationIgG N-glycans as potential biomarkers for determining galactose tolerance in Classical Galactosaemia. 2012, 105 (2):212-20 Mol. Genet. Metab.
JournalMolecular genetics and metabolism
AbstractN-glycan processing and assembly defects have been demonstrated in untreated and partially treated patients with Classical Galactosaemia. These defects may contribute to the ongoing pathophysiology of this disease. The aim of this study was to develop an informative method of studying differential galactose tolerance levels and diet control in individuals with Galactosaemia, compared to the standard biochemical markers. Ten Galactosaemia adults with normal intellectual outcomes were analyzed in the study. Five subjects followed galactose liberalization, increments of 300 mg to 4000 mg/day over 16 weeks, and were compared to five adult Galactosaemia controls on a galactose restricted diet. All study subjects underwent clinical and biochemical monitoring of red blood cell galactose-1-phosphate (RBC Gal-1-P) and urinary galactitol levels. Serum N-glycans were isolated and analyzed by normal phase high-performance liquid chromatography (NP-HPLC) with galactosylation of IgG used as a specific biomarker of galactose tolerance. IgG N-glycan profiles showed consistent individual alterations in response to diet liberalization. The individual profiles were improved for all, but one study subject, at a galactose intake of 1000 mg/day, with decreases in agalactosylated (G0) and increases in digalactosylated (G2) N-glycans. We conclude that IgG N-glycan profiling is an improved method of monitoring variable galactosylation and determining individual galactose tolerance in Galactosaemia compared to the standard methods.
- Classical galactosaemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis.
- Authors: Maratha A, Stockmann H, Coss KP, Estela Rubio-Gozalbo M, Knerr I, Fitzgibbon M, McVeigh TP, Foley P, Moss C, Colhoun HO, van Erven B, Stephens K, Doran P, Rudd P, Treacy E
- Issue date: 2016 Jul
- Fertility in classical galactosaemia, a study of N-glycan, hormonal and inflammatory gene interactions.
- Authors: Colhoun HO, Rubio Gozalbo EM, Bosch AM, Knerr I, Dawson C, Brady J, Galligan M, Stepien K, O'Flaherty R, Catherine Moss C, Peter Barker P, Fitzgibbon M, Doran PP, Treacy EP
- Issue date: 2018 Sep 19
- N-glycan abnormalities in children with galactosemia.
- Authors: Coss KP, Hawkes CP, Adamczyk B, Stöckmann H, Crushell E, Saldova R, Knerr I, Rubio-Gozalbo ME, Monavari AA, Rudd PM, Treacy EP
- Issue date: 2014 Feb 7
- High tolerance for oral galactose in classical galactosaemia: dietary implications.
- Authors: Bosch AM, Bakker HD, Wenniger-Prick LJ, Wanders RJ, Wijburg FA
- Issue date: 2004 Nov
- Validation of an automated ultraperformance liquid chromatography IgG N-glycan analytical method applicable to classical galactosaemia.
- Authors: Colhoun HO, Treacy EP, MacMahon M, Rudd PM, Fitzgibbon M, O'Flaherty R, Stepien KM
- Issue date: 2018 Sep